États-Unis · Actualité générale · New York Post

First-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: study

Publié par New York Post · États-Unis il y a 1 h

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by…

Lire l'article complet sur New York Post Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (nypost.com)

First-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: study

À lire aussi

Rescuers search for survivors after deadly earthquake in China’s Tibet region

Brazil's runoff: Lula's legacy vs. Bolsonaro's dynasty

Ahead of landmark climate trial in Canada, Indigenous youth eye impacts in the North

At least 16 people killed by powerful earthquake in Tibet

Can Angie Nixon prove Democrats can win in Florida?

DOJ asks appeals court to intervene for California mail-in ballot lawsuit

First-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: study

Partager

À lire aussi

Rescuers search for survivors after deadly earthquake in China’s Tibet region

Brazil's runoff: Lula's legacy vs. Bolsonaro's dynasty

Ahead of landmark climate trial in Canada, Indigenous youth eye impacts in the North

At least 16 people killed by powerful earthquake in Tibet

Can Angie Nixon prove Democrats can win in Florida?

DOJ asks appeals court to intervene for California mail-in ballot lawsuit